US2017225013A1PendingUtilityA1

System and method for optogenetic therapy

70
Assignee: CIRCUIT THERAPEUTICS INCPriority: Nov 21, 2012Filed: Apr 3, 2017Published: Aug 10, 2017
Est. expiryNov 21, 2032(~6.4 yrs left)· nominal 20-yr term from priority
A61P 9/12A61M 2037/0023A61B 2017/3413A61M 5/20A61K 38/168A61N 5/0601A61N 5/062A61M 2205/3576A61K 38/164A61N 1/0551A61K 48/0075A61N 5/0622A61N 2005/0651A61K 41/0057A61N 1/3605A61M 5/142A61N 2005/063A61N 2005/0626A61N 2005/0665A61B 17/00234A61K 41/00A61K 38/177A61K 48/00A61K 38/16A61M 25/0105A61N 2005/0653A61M 2037/0061A61M 25/0147A61N 2005/0643A61M 37/0015A61N 2005/0627A61N 1/36053A61M 2205/50A61N 2005/0612A61B 17/3403A61N 2005/0631A61N 2005/067A61N 5/067
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Claims

exact text as granted — not AI-modified
1 . A system for creating a directed action potential in a targeted nerve comprising light sensitive protein and coupled to a spinal cord of a patient, comprising:
 a. an implantable optical applicator configured to engage the targeted nerve and to deliver light to the targeted nerve, the implantable optical applicator operatively coupled to a light source configured to deliver photons to the implantable optical applicator which may be emitted by the implantable optical applicator into the targeted nerve to cause a membrane polarization change in the targeted nerve;   b. an implantable electrical stimulation applicator configured to engage the targeted nerve, the implantable electrical stimulation applicator operatively coupled to a power source configured to deliver electrons to the implantable electrical stimulation applicator which may be emitted by the implantable electrical stimulation applicator into the targeted nerve to cause a membrane polarization change in the targeted nerve; and   c. a controller operatively coupled to the light source and the power source and configured to cause both current to flow to the implantable electrical stimulation applicator and photons to be directed to the implantable optical applicator, such that an action potential is created which propagates in a first desired direction along the nerve, and which does not substantially propagate in a reverse direction along the nerve.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.